share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Li Dean Y

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Li Dean Y

Recursion Pharmaceuticals | 4：持股變動聲明-董事 Li Dean Y
美股sec公告 ·  06/06 06:17
牛牛AI助理已提取核心訊息
Dean Y. Li, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a stock grant transaction on June 3, 2024. A total of 13,097 shares of Class A Common Stock were acquired at no cost, as part of the grant. Following this transaction, Li directly holds 72,186 shares of the company's stock. Additionally, Li has indirect beneficial ownership of 3,112,844 shares through various trusts, including the Dean Li and Ruth Li Revocable Trust, Dean Y. Li GRAT, and Dean Y. Li 2021 Family Trust.
Dean Y. Li, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a stock grant transaction on June 3, 2024. A total of 13,097 shares of Class A Common Stock were acquired at no cost, as part of the grant. Following this transaction, Li directly holds 72,186 shares of the company's stock. Additionally, Li has indirect beneficial ownership of 3,112,844 shares through various trusts, including the Dean Li and Ruth Li Revocable Trust, Dean Y. Li GRAT, and Dean Y. Li 2021 Family Trust.
Dean Y. Li與Recursion Pharmaceuticals, Inc. [RXRX]相關，於2024年6月3日完成了股份授予交易。作為授予的一部分，共獲得13,097股A類普通股，並未花費成本。此後，Li直接持有公司股票的72186股。此外，Li通過各種信託間接持有3112844股受益所有權，包括Dean Li和Ruth Li可撤銷信託，Dean Y. Li GRAT和Dean Y. Li 2021家庭信託。
Dean Y. Li與Recursion Pharmaceuticals, Inc. [RXRX]相關，於2024年6月3日完成了股份授予交易。作為授予的一部分，共獲得13,097股A類普通股，並未花費成本。此後，Li直接持有公司股票的72186股。此外，Li通過各種信託間接持有3112844股受益所有權，包括Dean Li和Ruth Li可撤銷信託，Dean Y. Li GRAT和Dean Y. Li 2021家庭信託。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。